AstraZeneca strikes clinical collaboration with Summit to test ADC sonesitatug vedotin with ivonescimab in GI cancers
Bitget2026/09/29 10:42- AstraZeneca agreed to invest USD 2 billion in Summit Therapeutics through newly issued preferred stock convertible to common shares.
- Investment implies rights equivalent to about 12% of Summit’s outstanding common stock, or about 10.6% on a fully diluted basis.
- Separate clinical collaboration will test sonesitatug vedotin, a Claudin-18.2 ADC, combined with Summit’s PD-1/VEGF bispecific ivonescimab in GI cancers.
- Companies will supply their own medicines for combination trials, share trial costs, retain development and commercial rights to their respective products.
- Memorandum of understanding targets a broader global program pairing ivonescimab with AstraZeneca oncology drugs, including additional ADCs.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bitcoin plunged nearly $2,000 in 20 minutes, about $400 millions in long positions liquidated.
According to the data, on October 6, 2026, bitcoin fell more than 5% during the session, plummeting nearly $2,000 within about 20 minutes, resulting in the liquidation of approximately $400 million in leveraged long positions.
AI cloud startup Lambda, backed by Nvidia, races toward IPO: planning to raise up to $4 billions in the final pre-listing round, with a valuation of $14.5 billions
Cloud computing company Lambda, backed by NVIDIA, is launching its final funding round before its IPO, aiming to raise up to 4 billion US dollars.
United States Dollar Index retakes 102.00 as bulls eye YTD peak ahead of FOMC Minutes
McDonald's (MCD.US) sued over AI pricing tool, accused of facilitating algorithmic collusion among U.S. franchisees
McDonald's (MCD.US) is facing a federal lawsuit. The complaint alleges that its AI-enhanced pricing tool violates antitrust laws by sharing non-public data with franchisees who may compete in the same market.
Crypto prices
More
